[1] Chang CB,Kim TK,Kang YG, et al. Prevalence of osteoporosis in female patients with advanced knee osteoarthritis undergoing total knee arthroplasty. J Korean Med Sci. 2014;29(10):1425-1431.[2] Lingard EA,Mitchell SY,Francis RM, et al. The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty. Age Ageing. 2010;39(2):234-239.[3] Labuda A,Papaioannou A,Pritchard J, et al. Prevalence of osteoporosis in osteoarthritic patients undergoing total hip or total knee arthroplasty. Arch Phys Med Rehabil. 2008;89(12):2373-2374.[4] Spinarelli A,Petrera M,Vicenti G, et al. Total knee arthroplasty in elderly osteoporotic patients. Aging Clin Exp Res. 2011; 23(2 Suppl):78-80.[5] Lee DH,Padhy D,Lee SH, et al. Osteoporosis affects component positioning in computer navigation-assisted total knee arthroplasty. Knee.2012; 19(3):203-207.[6] Kim KK,Won YY,Heo YM, et al. Changes in bone mineral density of both proximal femurs after total knee arthroplasty. Clin Orthop Surg. 2014;6(1):43-48.[7] Huang CC,Jiang CC,Hsieh CH, et al. Local bone quality affects the outcome of prosthetic total knee arthroplasty. J Orthop Res. 2015. [8] Carulli C,Civinini R,Matassi F, et al. The use of anti-osteoporosis drugs in total knee arthroplasty. Aging Clin Exp Res. 2011;23(2 Suppl):38-39.[9] Stewart A,Black A,Robins SP, et al. Bone density and bone turnover in patients with osteoarthritis and osteoporosis. J Rheumatol. 1999;26(3):622-626.[10] Hart DJ,Mootoosamy I,Doyle DV, et al. The relationship between osteoarthritis and osteoporosis in the general population: the Chingford Study. Ann Rheum Dis. 1994; 53(3):158-162.[11] Cosman F,de Beur SJ,LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381.[12] Petersson IF,Boegard T,Saxne T, et al. Radiographic osteoarthritis of the knee classified by the Ahlback and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis. 1997;56(8):493-496.[13] Jauregui JJ,Cherian JJ,Pierce TP, et al. Long-Term Survivorship and Clinical Outcomes Following Total Knee Arthroplasty. J Arthroplasty. 2015. [14] Thukral R, Marya S, Singh C. Management of distal femoral periprosthetic fractures by distal femoral locking plate: A retrospective study. Indian J Orthop. 2015;49(2): 199-207.[15] Yoo JD, Kim NK. Periprosthetic fractures following total knee arthroplasty. Knee Surg Relat Res. 2015; 27(1):1-9.[16] Huang ZY,Ma J,Shen B, et al. Intraoperative Femoral Condylar Fracture during Primary Total Knee Arthroplasty: Report of Two Cases. Orthop Surg. 2015; 7(2):180-184.[17] Whitehouse MR, Mehendale S. Periprosthetic fractures around the knee: current concepts and advances in management. Curr Rev Musculoskelet Med. 2014; 7(2):136-144.[18] Shawen SB,Belmont PJ Jr,Klemme WR, et al. Osteoporosis and anterior femoral notching in periprosthetic supracondylar femoral fractures: a biomechanical analysis. J Bone Joint Surg Am. 2003; 85-A(1):115-121.[19] Prieto-Alhambra D,Javaid MK,Maskell J, et al. Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. 2011;70(1):134-138.[20] Raisz LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med. 1988;318(13):818-828.[21] Foss MV, Byers PD. Bone density, osteoarthrosis of the hip, and fracture of the upper end of the femur. Ann Rheum Dis.1972; 31(4):259-264.[22] Hahn MH, Won YY. Bone mineral density changes after total knee replacement in women over the age of 65. J Bone Metab.2013; 20(2):105-109.[23] Hannan MT,Anderson JJ,Zhang Y, et al. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum.1993; 36(12):1671-1680.[24] Hahn MH AJ, Lee KS. Bone mineral density differences of both hips in women with knee osteoarthritis over the age of 65. Korean J Bone Metab. 2010;17:87-93.[25] Sezer I,Illeez OG,Tuna SD, et al. The relationship between knee osteoarthritis and osteoporosis. Eurasian J Med. 2010;42(3):124-127.[26] 蔡科,范占江.中老年女性原发性骨质疏松症危险因素[J]. 中国骨质疏松杂志, 2014,20(9):1133-1137.[27] Erlandson KM, Guaraldi G, Falutz J. More than osteoporosis: age-specific issues in bone health. Curr Opin HIV AIDS, 2016.[28] Geusens PP, van den Bergh JP. Osteoporosis and osteoarthritis: shared mechanisms and epidemiology. Curr Opin Rheumatol. 2016;28(2):97-103.[29] Kanazawa I. [Diabetes-related osteoporosis]. Nihon Rinsho. 2015;73(10):1718-1722.[30] 王文娇.骨质疏松患者骨密度与骨质疏松危险因素的相关性研究[D]. 山西医科大学, 2015.[31] 杨丹,栗平,赵平. 探讨骨质疏松性骨折的相关影响因素及预防[J].中国骨质疏松杂志, 2014,20(2):152-155.[32] 蔡科,范占江.中老年女性原发性骨质疏松症危险因素[J]. 中国骨质疏松杂志, 2014,20(9):1133-1137.[33] 王宁,刘玉杰.骨质疏松的发病机制与危险因素[J].中国骨质疏松杂志, 2013,19(5):537-540.[34] 黄淑纾,林华.老年性骨质疏松性骨折的发生与预防[J].中国骨质疏松杂志, 2012,18(4):381-386.[35] 王奔.药物预防绝经后骨质疏松症妇女脆性骨折的meta分析[D].天津医科大学, 2013.[36] 余舒芳,林建华,李毅中,等.骨质疏松性骨折二级预防的综合管理—骨质疏松性骨折二级预防示范基地福州中心专家共识[J]. 中华关节外科杂志(电子版), 2014,8(6):808-812.[37] 陶天遵,邱贵兴,朱汉民,等 原发性骨质疏松症的治疗与预防[J].中华骨与关节外科杂志, 2015,(5):377-384.[38] 黄琪仁.钙、维生素D与原发性骨质疏松症[J].中国实用妇科与产科杂志, 2014,30(5):336-340.[39] Curtis EM, Moon RJ, Dennison EM, et al. Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond). 2015;15 Suppl 6:s92-s96.[40] DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010;340:b5463.[41] 刘斌, 王济纬, 张凯跃, 等. 唑来膦酸注射液与鲑鱼降钙素治疗骨质疏松性腰背痛的临床疗效比较: 2014浙江省骨质疏松与骨矿盐疾病学术年会暨国家级继教项目“骨质疏松症和骨质疏松性骨折诊治进展”专题研讨会,中国浙江杭州, 2014[C].[42] 高雷,任艳,高华增. 唑来膦酸对骨质疏松骨含量的影响[J]. 中国骨质疏松杂志, 2015,21(1):72-74.[43] 张庆丰.鲑鱼降钙素鼻喷剂治疗绝经后骨质疏松患者骨密度及骨转换指标对照观察[J].中医药临床杂志, 2016, (1): 63-65.[44] 杨惠光,唐天驷,李忠泽,等.鲑鱼降钙素治疗老年骨质疏松症的临床研究[J].中国骨质疏松杂志, 2008,14(10):751-753.[45] 张学昌,黄洪,储辉,等. 鲑鱼降钙素联合金天格胶囊治疗老年性骨质疏松症的临床观察[J]. 中国骨质疏松杂志, 2014, 20(6):673-675.[46] 历宝国,齐秀杰,闫立娜,等.阿仑膦酸钠联合降钙素治疗骨质疏松的疗效评价[J]. 临床合理用药杂志, 2014,7(25):44-45. |